Recent studies suggest that PPAR-β may be a target for nonsteroidalantiinflammatory drugs (NSAIDs)-induced tumor suppression in colorectal tumors.PPAR-γ is expressed at high level in adipose tissue and is a critical regulatorof adipocyte differentiation. The gene discussed is PPARG; the disease is colorectal neoplasm.